Drugging the undruggable: activity-based protein profiling offers opportunities for targeting the KLK activome-Reference-Cited by-同舟云学术

Drugging the undruggable: activity-based protein profiling offers opportunities for targeting the KLK activome

Published:2022-02-06 Issue:1 Volume:23 Page:136-138
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Lee Kristi Y.¹^ORCID,Chau Cindy H.¹,Price Douglas K.¹,Figg William D.¹^ORCID

Affiliation:

1. Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Funder

reported

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2022.2033059

Reference14 articles.

1. Activity-Based Protein Profiling: From Enzyme Chemistry to Proteomic Chemistry

2. Metabolic Changes Are Associated with Melphalan Resistance in Multiple Myeloma

3. Activity-Based Protein Profiling Reveals Potential Dasatinib Targets in Gastric Cancer

4. Target Profiling of an Anticancer Drug by an In Situ Approach

5. Activity-based protein profiling: Recent advances in medicinal chemistry

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide-based PROTACs: Current Challenges and Future Perspectives;Current Medicinal Chemistry;2024-01

2. Mapping the Evolution of Activity-Based Protein Profiling: A Bibliometric Review;Advanced Pharmaceutical Bulletin;2023-05-20

3. Novel specific activity-based probes validate KLK proteases as druggable targets;Cancer Biology & Therapy;2022-06-02